BACKGROUND: The RIFLE criteria (risk, injury, failure, loss, end stage) are new consensus definitions for acute kidney injury (AKI) associated with increased mortality; however, they have not been applied in lung transplantation (LTx). Using the RIFLE criteria, we examined the effect of AKI on outcomes and cost in LTx. METHODS: We retrospectively reviewed all LTx patients at our institution since the lung allocation score (LAS) system was initiated (May 2005-August 2010). Using the Modification of Diet in Renal Disease formula, we assigned appropriate RIFLE class (R, I, F) comparing baseline creatinine to peak levels in the first 7 days after LTx. Generalized linear models assessed the effect of AKI on in-hospital and 1-year mortality. Hospital charges were used to examine the financial effect of AKI. RESULTS: During the study, 106 LTx were performed. Excluding patients bridged to LTx with extracorporeal membrane oxygenation, 84 (86%) lived 1 year. Median LAS was 37.1 (interquartile range, 34.1-45.2). RIFLE status was I or F in 39 (36.7%), and 14 (13.2%) required renal replacement therapy (RRT). After adjusting for LAS, RIFLE-F had an increased relative rate (RR) of in-hospital mortality (RR, 4.76, 95% confidence interval [CI], 1.65-13.7, p = 0.004) and 1-year mortality (RR, 3.17, 95% CI 1.55-6.49, p = 0.002). RIFLE-R and I were not associated with higher in-hospital or 1-year mortality. Post-operative RRT was associated with increased in-hospital (RR, 28.2; 95% CI, 6.18-128.1; p < 0.001) and 1-year mortality (RR, 4.97; 95% CI, 1.54-16.0; p < 0.001). AKI patients had higher median hospital charges of $168,146 vs $143,551 for no AKI (p = 0.02). CONCLUSIONS: This study shows high rates of AKI using the new RIFLE criteria in LTx. RIFLE-F is associated with higher in-hospital and 1-year mortality. Less severe degrees of AKI are not associated with increased mortality. The financial burden associated with AKI is significant.
BACKGROUND: The RIFLE criteria (risk, injury, failure, loss, end stage) are new consensus definitions for acute kidney injury (AKI) associated with increased mortality; however, they have not been applied in lung transplantation (LTx). Using the RIFLE criteria, we examined the effect of AKI on outcomes and cost in LTx. METHODS: We retrospectively reviewed all LTxpatients at our institution since the lung allocation score (LAS) system was initiated (May 2005-August 2010). Using the Modification of Diet in Renal Disease formula, we assigned appropriate RIFLE class (R, I, F) comparing baseline creatinine to peak levels in the first 7 days after LTx. Generalized linear models assessed the effect of AKI on in-hospital and 1-year mortality. Hospital charges were used to examine the financial effect of AKI. RESULTS: During the study, 106 LTx were performed. Excluding patients bridged to LTx with extracorporeal membrane oxygenation, 84 (86%) lived 1 year. Median LAS was 37.1 (interquartile range, 34.1-45.2). RIFLE status was I or F in 39 (36.7%), and 14 (13.2%) required renal replacement therapy (RRT). After adjusting for LAS, RIFLE-F had an increased relative rate (RR) of in-hospital mortality (RR, 4.76, 95% confidence interval [CI], 1.65-13.7, p = 0.004) and 1-year mortality (RR, 3.17, 95% CI 1.55-6.49, p = 0.002). RIFLE-R and I were not associated with higher in-hospital or 1-year mortality. Post-operative RRT was associated with increased in-hospital (RR, 28.2; 95% CI, 6.18-128.1; p < 0.001) and 1-year mortality (RR, 4.97; 95% CI, 1.54-16.0; p < 0.001). AKI patients had higher median hospital charges of $168,146 vs $143,551 for no AKI (p = 0.02). CONCLUSIONS: This study shows high rates of AKI using the new RIFLE criteria in LTx. RIFLE-F is associated with higher in-hospital and 1-year mortality. Less severe degrees of AKI are not associated with increased mortality. The financial burden associated with AKI is significant.
Authors: Daniel Kreisel; Alexander S Krupnick; Varun Puri; Tracey J Guthrie; Elbert P Trulock; Bryan F Meyers; G Alexander Patterson Journal: J Thorac Cardiovasc Surg Date: 2010-11-19 Impact factor: 5.209
Authors: George J Arnaoutakis; Jeremiah G Allen; Christian A Merlo; Brigitte E Sullivan; William A Baumgartner; John V Conte; Ashish S Shah Journal: J Heart Lung Transplant Date: 2010-09-24 Impact factor: 10.247
Authors: T M Egan; S Murray; R T Bustami; T H Shearon; K P McCullough; L B Edwards; M A Coke; E R Garrity; S C Sweet; D A Heiney; F L Grover Journal: Am J Transplant Date: 2006 Impact factor: 8.086
Authors: Judy Currey; David V Pilcher; Andrew Davies; Carlos Scheinkestel; Mari Botti; Michael Bailey; Greg Snell Journal: J Thorac Cardiovasc Surg Date: 2009-11-11 Impact factor: 5.209
Authors: Christian A Merlo; Eric S Weiss; Jonathan B Orens; Marvin C Borja; Marie Diener-West; John V Conte; Ashish S Shah Journal: J Heart Lung Transplant Date: 2009-08 Impact factor: 10.247
Authors: Jeffrey B Hoag; Manchang Liu; R Blaine Easley; Martin F Britos-Bray; Priya Kesari; Heitham Hassoun; Mark Haas; Rubin M Tuder; Hamid Rabb; Brett A Simon Journal: Am J Physiol Renal Physiol Date: 2008-02-06
Authors: Eric A J Hoste; Gilles Clermont; Alexander Kersten; Ramesh Venkataraman; Derek C Angus; Dirk De Bacquer; John A Kellum Journal: Crit Care Date: 2006-05-12 Impact factor: 9.097
Authors: Matti Peperhove; Van Dai Vo Chieu; Mi-Sun Jang; Marcel Gutberlet; Dagmar Hartung; Susanne Tewes; Gregor Warnecke; Christiane Fegbeutel; Axel Haverich; Wilfried Gwinner; Frank Lehner; Jan Hinrich Bräsen; Hermann Haller; Frank Wacker; Faikah Gueler; Katja Hueper Journal: Eur Radiol Date: 2017-07-14 Impact factor: 5.315
Authors: Asishana A Osho; Sameer A Hirji; Anthony W Castleberry; Michael S Mulvihill; Asvin M Ganapathi; Paul J Speicher; Babatunde Yerokun; Laurie D Snyder; Robert D Davis; Mathew G Hartwig Journal: Clin Transplant Date: 2017-04-17 Impact factor: 2.863
Authors: Timothy J George; George J Arnaoutakis; Claude A Beaty; Matthew R Pipeling; Christian A Merlo; John V Conte; Ashish S Shah Journal: Ann Thorac Surg Date: 2012-02-10 Impact factor: 4.330
Authors: Dean J Arnaoutakis; George J Arnaoutakis; Christopher J Abularrage; Robert J Beaulieu; Ashish S Shah; Duke E Cameron; James H Black Journal: Ann Vasc Surg Date: 2015-03-07 Impact factor: 1.466
Authors: Su Hwan Lee; Moo Suk Park; Joo Han Song; Young Sam Kim; Jin Gu Lee; Hyo Chae Paik; Song Yee Kim Journal: J Thorac Dis Date: 2017-10 Impact factor: 2.895